Literature DB >> 2450414

Studies on FK506 in experimental organ transplantation.

T Ochiai1, K Sakamoto, M Nagata, K Nakajima, T Goto, S Hori, T Kenmochi, T Nakagori, T Asano, K Isono.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2450414

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  8 in total

Review 1.  Neural transplantation for Parkinson's disease.

Authors:  I Date; T Ohmoto
Journal:  Cell Mol Neurobiol       Date:  1999-02       Impact factor: 5.046

2.  The effect of FK 506 and CyA on the Lewis rat renal ischemia model.

Authors:  M A Nalesnik; H S Lai; N Murase; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

3.  Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression.

Authors:  L A Valdivia; J J Fung; A J Demetris; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

4.  Effect of FK506 and cyclosporine on primary and secondary skin allograft survival in mice.

Authors:  Z Lagodzinski; A Górski; M Wasik
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

Review 5.  FK506 and the role of immunophilins in nerve regeneration.

Authors:  B G Gold
Journal:  Mol Neurobiol       Date:  1997-12       Impact factor: 5.590

6.  Gut microbiota-dependent modulation of innate immunity and lymph node remodeling affects cardiac allograft outcomes.

Authors:  Jonathan S Bromberg; Lauren Hittle; Yanbao Xiong; Vikas Saxena; Eoghan M Smyth; Lushen Li; Tianshu Zhang; Chelsea Wagner; W Florian Fricke; Thomas Simon; Colin C Brinkman; Emmanuel F Mongodin
Journal:  JCI Insight       Date:  2018-10-04

Review 7.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

8.  Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients.

Authors:  M Sakr; T Hassanein; J Gavaler; K Abu-Elmagd; J Fung; R Gordon; T Starzl; D Van Thiel
Journal:  Transplantation       Date:  1992-04       Impact factor: 4.939
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.